drugset / Trial / NCT01654224

Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting

NCT01654224 ↗

RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of the study is to compare the performance of two currently available influenza (flu) vaccines. This study will try and determine if the high dose flu vaccine provides protection that is the same or better than that of regular dose flu vaccine. Both the regular dose and the high dose flu vaccines are approved by the FDA for use in older adults.

Timeline

Start
2011-11
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator High Dose Inactivated Influenza Vaccine Vaccine 180 ug —
Comparator High Dose Inactivated Influenza Vaccine Vaccine 0.5 ml —
Comparator Standard Dose Inactivated Influenza Vaccine Vaccine 45 ug —
Comparator Standard Dose Inactivated Influenza Vaccine Vaccine 0.5 ml —

Indications